Supportive monitoring and disease management through the internet

• Verfasst von: Kordy, Hans [VerfasserIn]
• Verfasst von: Backenstraß, Matthias [VerfasserIn]
• Verfasst von: Hüsing, Johannes [VerfasserIn]
• Verfasst von: Wolf, Markus [VerfasserIn]
• Verfasst von: Aulich, Kai [VerfasserIn]
• Verfasst von: Bürgy, Martin [VerfasserIn]
• Verfasst von: Puschner, Bernd [VerfasserIn]
• Verfasst von: Rummel-Kluge, Christine [VerfasserIn]
• Verfasst von: Vedder, Helmut [VerfasserIn]
• Titel: Supportive monitoring and disease management through the internet
• Titelzusatz: an internet-delivered intervention strategy for recurrent depression
• Verf.angabe: Hans Kordy, Matthias Backenstrass, Johannes Hüsing, Markus Wolf, Kai Aulich, Martin Bürgy, Bernd Puschner, Christine Rummel-Kluge, Helmut Vedder
• E-Jahr: 2013
• Jahr: 23 August 2013
• Umfang: 11 S.
• Fussnoten: Gesehen am 01.12.2021
• Titel Quelle: Enthalten in: Contemporary clinical trials
• Ort Quelle: Amsterdam [u.a.] : Elsevier Science, 2005
• Jahr Quelle: 2013
• Band/Heft Quelle: 36(2013), 2, Seite 327-337
• ISSN Quelle: 1559-2030
• DOI: doi:10.1016/j.cct.2013.08.005
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Disease management
• Sach-SW: E-health
• Sach-SW: Internet
• Sach-SW: Recurrent depression
• Sach-SW: Supportive monitoring
• K10plus-PPN: 1752410955

Abstract

Major depression is a highly prevalent, disabling disorder associated with loss of quality of life and large economic burden for the society. Depressive disorders often follow a chronic or recurrent course. The risk of relapses increases with each additional episode. The internet-deliverable intervention strategy SUMMIT (SUpportive Monitoring and Disease Management over the InTernet) for patients with recurrent depression has been developed with the main objectives to prolong symptom-free phases and to shorten symptom-loaden phases. This paper describes the study design of a six-sites, three-arm, randomized clinical trial intended to evaluate the efficacy of this novel strategy compared to treatment as usual (TAU). Two hundred thirty six patients who had been treated for their (at least) third depressive episode in one of the six participating psychiatric centers were randomized into one of three groups: 1) TAU plus a twelve-month SUMMIT program participation with personal support or 2) TAU plus a twelve-month SUMMIT program participation without personal support, or 3) TAU alone. Primary outcome of this study is defined as the number of “well weeks” over 24months after index treatment assessed by blind evaluators based on the Longitudinal Interval Follow-Up Evaluation. If efficacious, the low monetary and nonmonetary expenditures of this automated, yet individualized intervention may open new avenues for providing an acceptable, convenient, and affordable long-term disease management strategy to people with a chronic mental condition such as recurrent depression.